Inhibition of arachidonic acid release by cytosolic phospholipase A 2 is involved in the antiapoptotic effect of FK506 and cyclosporin A on astrocytes exposed to simulated ischemia in vitro

Journal of Pharmacological Sciences

Volumn 102, Issue 1, 2006, Pages 77-87

  Gabryel, Bozena ^a   Chalimoniuk, Malgorzata ^b   Stolecka, Anna ^c   Waniek, Katarzyna ^c   Langfort, Jozef ^c   Malecki, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INSTITUTE OF SPORT SCIENCES   (Poland)

Author keywords

Apoptosis; Astrocyte; Cyclosporin A; Cytosolic phospholipase A 2; FK506

Indexed keywords

ARACHIDONIC ACID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL FUNCTION; CELL VIABILITY; GLIA CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 33748979291     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060605     Document Type: Article

References (70)

1. Phillis JW, Diaz FG, O'Regan MH, Pilitsis JG. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Brain Res. 2002;957:12-24.
2. Tachibana T, Shiiya N, Kunihara T, Wakamatsu Y, Kudo AF, Ooka T, et al. Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg. 2005;129:123-128.
3. Murozono M, Matsumoto S, Matsumoto E, Isshiki A, Watanabe Y. Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice. Eur J Pharmacol. 2004;498:115-118.
4. Domanska-Janik K, Buzanska L, Dluzniewska J, Kozlowska H, Sarnowska A, Zablocka B. Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm. Brain Res Mol Brain Res. 2004;121:50-59.
5. Reyman KG, Schmidt W, Striggow F, Reiser G. Immunophilins in the CNS potential targets for neuroprotective processes in the brain after cerebral ischemia. Restor Neurol Neurosci. 2000;16:33.
6. Ivery MT, Weiler L. Modeling the interaction between FK506 and FKBP12: a mechanisms for formation of the calcineurin inhibitory complex. Bioorg Med Chem. 1997;5:217-232.
7. Garcia-Cozar FJ, Okamura H, Aramburu JF, Shaw KTY, Pelletier R, Showalter R, et al. Two-side interaction of nuclear factor of activated T cells with activated calcineurin. J Biol Chem. 1998;273:23877-23883.
8. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med. 1997;3:421-428.
9. Toung TJ, Bhardwaj A, Dawson VL, Dawson TM, Traystman RJ, Hurn PD. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats. Stroke. 1999;30:1279-1285.
10. Dalkara T, Yoshida T, Irikura K, Moskowitz MA. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 1994;33:1447-1452.
11. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci. 1996;16:2479-2487.
12. Kristian T, Siesjö BK. Calcium in ischemic cell death. Stroke. 1998;29:705-718.
13. Charters AR, Kobayashi M, Butcher SP. The subcellular distribution of FK506 binding proteins in rat brain. Biochem Soc Trans. 1994;22:412S.
14. Lyons WE, Steiner JP, Snyder SH, Dawson, TM. Neuronal regeneration enhance the expression of the immunophilin FKBP-12. J Neurosci. 1995;15:2985-2994.
15. Matsuda T, Takuma K, Asano S, Kishida K, Mori K, Maeda S, et al. Protection by calcineurin inhibitors against reperfusion injury of cultured rat astrocytes. J Neurochem. 1998;70:2004-2011.
16. Hashimoto T, Kawamata T, Saito N, Sasaki M, Nakai M, Niu S, et al. Isoform-specific redistribution of calcineurin A alpha and A beta in the hippocampal CA1 region of gerbils after transient ischemia. J Neurochem. 1998;70:1289-1298.
17. Zawadzka M, Kaminska B. Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci. 2003;22:202-209.
18. Aschner M. Astrocytic functions and physiological reactions to injury: the potential to induce and/or exacerbate neuronal dysfunction - a forum position paper. Neurotoxicology. 1998;19:7-18.
19. Gabryel B, Trzeciak HI. Role of astrocytes in pathogenesis of ischemic brain injury. Neurotoxicity Res. 2001;3:205-221.
20. Siesjö BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab. 1989;9:127-140.
21. Morley P, Hogan MJ, Hakim AM. Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol. 1994;4:37-47.
22. Schievella AR, Regier MK, Smith WL, Lin LL. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem. 1995;270:30749-30754.
23. Cummings BS, McHowat J, Schnellmann RG. Phospholipase A(2)s in cell injury and death. J Pharmacol Exp Ther. 2000;294:793-799.
24. Gijon MA, Leslie CC. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol Mar. 1999;65:330-336.
25. Bonventre JV. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J Lipid Mediat Cell Signal. 1996;14:15-23.
26. Xu J, Weng YI, Simonyi A, Krugh BW, Liao Z, Weisman GA, et al. Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem. 2002;83:259-270.
27. Sun GY, Xu J, Jensen MD, Yu S, Wood WG, Gonzalez FA, et al. Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Mol Neurobiol. 2005;31:27-41.
28. Saluja I, Song D, O'Regan MH, Phillis JW. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett. 1997;233:97-100.
29. Traystman RJ, Kirch JR, Koehler RC. Oxygen radical mechanism of brain injury following ischemia and reperfusion. J Appl Physiol. 1991;71:1185-1195.
30. Volterra A, Trotti D, Cassutti P, Tromba C, Galimberti R, Lecchi P, et al. A role for the arachidonic cascade in fast synaptic modulation: ion channels and transmitter uptake systems as target proteins. Adv Exp Med Biol. 1992;318:147-158.
31. Hertz L, Juurlink BHJ, Szuchet S. Cell cultures. In: Lajtha A, editor. Handbook of Neurochemistry. New York: Plenum Press; 1985. p. 603-661.
32. Simmons ML, Murphy S. Induction of nitric oxide synthase in glial cells. J Neurochem. 1992;59:897-905.
33. Mosman T. Rapid, colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55-63.
34. Shearman MS, Hawtin SR, Tailor VJ. The intracellular component of cellular 3-(4,5-dimethylthazol-2-yl)-2,5-diphenyltetrazolinum bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J Neurochem. 1995;65:218-227.
35. Mattson MP, Barger SW, Begley JG, Mark RJ. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 1995;46:187-216.
36. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine fluorescent indicator of membrane potential. Biochemistry. 1991;30:4480-4486.
37. Samanta S, Perkinton M, Morgan M, Williams RJ. Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J Neurochem. 1998;70:2082-2090.
38. Xu J, Chalimoniuk M, Shu Y, Simonyi A, Sun AY, Gonzalez FA, et al. Prostaglandin E2 production in astrocytes, regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fatty Acids. 2003;69:437-448.
39. Bradford MM. A rapid and sensitive method for the quantification of 'microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem. 1976;72:248-251.
40. Uchino H, Elmer E, Uchino K, Lindvall O, Siesjö BK. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischemia in the rat. Acta Physiol Scand. 1995;155:469-471.
41. Ciechomska I, Pyrzynska B, Kazmierczak P, Kaminska B. Inhibition of Akt kinase signaling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene. 2003;23:7617-7627.
42. Pyrzynska B, Lis A, Mosieniak G, Kaminska, B. Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem Int. 2001;38:409-415.
43. Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura KI, et al. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat therapeutic time window for FK506 in transient focal ischemia. Neurol Res. 2001;23:755-760.
44. 125I]PK-11195. Neurol Res. 2000;22:630-633.
45. Ide T, Morikawa E, Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci Lett. 1996;204:157-160.
46. Moriwaki A, Lu YF, Tomizawa K, Matsui H. An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. Neuroscience. 1998;86:855-865.
47. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993;90:9808-9812.
48. Manev H, Favaron M, Candeo P, Fadda E, Lipartiti M, Milani D. Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate. Brain Res. 1993;624:331-335.
49. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci. 1997;17:6939-6946.
50. 2+-activated cell death in mammalian cells. J Cell Biol. 1995;131:735-743.
51. Miyata K, Omori N, Uchino H, Yamaguchi T, Isshiki A, Shibasaki, F. Involvement of the brain-derived neurotrophic factor /TrkB pathway in neuroprotective effect of cyclosporin A in forebrain ischemia. Neuroscience. 2001;105:571-578.
52. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 1999;284:339-343.
53. Gabryel B, Adamek M, Trzeciak HI. Does trimetazidine exert cytoprotective activity on astrocytes subjected to hypoxia in vitro? Neurotoxicology. 2001;22:455-465.
54. Gabryel B, Adamczyk J, Huzarska M, Pudełko A, Trzeciak HI. Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro. Neurotoxicology. 2002;23:385-395.
55. Asai A, Qiu J, Narita Y, Chi S, Saito N, Shinoura N, et al. High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem. 1999;274:34450-34458.
56. Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci. 2001;26:112-117.
57. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, Scorrano L, et al. Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway. J Biol Chem. 2004;279:25219-25225.
58. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta. 1995;1241:139-176.
59. Khaspekov L, Friberg H, Halestrap A, Viktorov I, Wieloch T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur J Neurosci. 1998;11:3194-3198.
60. Nicolli A, Basso E, Petronilli V, Wenger, RM, Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem. 1996;271:2185-2192.
61. Uchino H, Minamikawa-Tachino R, Krystian T, Perkins G, Narazaki M, Siesjö BK, et al. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis. 2002;10:219-233.
62. Bazan NG. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta. 1970;218:1-10.
63. Hillered L, Chan PH. Role of arachidonic acid and other free fatty acids in mitochondrial dysfunction in brain ischemia. J Neurosci Res. 1988;20:451-456.
64. Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol. 1990;258:C755-C786.
65. Toborek M, Malecki A, Garrido R, Mattson MP, Hennig B, Young B. Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J Neurochem.1999;73:684-692.
66. Farooqui AA, Yang HC, Rosenberger TA, Horrocks LA. Phospholipase A2 and its role in brain tissue. J Neurochem. 1997;69:889-901.
67. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi, P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apototic signaling. J Biol Chem. 2001;276:12035-12040.
68. Palomba L, Persichini T, Mazzone V, Colasanti M, Cantoni, O. Inhibition of nitric-oxide synthase-I (NOS-I)-dependent nitric oxide production by lipopolysaccharide plus interferon-gamma is mediated by arachidonic acid. Effects on NFkappaB activation and late inducible NOS expression. J Biol Chem. 2004;279:29895-29901.
69. Hamasaki Y, Kobayashi I, Matsumoto S, Zaitu M, Muro E, Ichimaru T, et al. Inhibition of leukotriene production by FK506 in rat basophilic leukemia-1 cells. Pharmacology. 1995;50:137-145.
70. Pompeo A, Baldassare M, Luini A, Buccione, R. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells. Life Sci. 1999;64:837-846.